Phase I Study Evaluating Dose De-escalation of Sorafenib with Metformin and Atorvastatin in Hepatocellular Carcinoma (SMASH).
Oncologist
; 27(3): 165-e222, 2022 03 11.
Article
in En
| MEDLINE
| ID: mdl-35274724
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Liver Neoplasms
/
Metformin
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Oncologist
Journal subject:
NEOPLASIAS
Year:
2022
Type:
Article
Affiliation country:
India